Ładuje się......
Targeting aggressive prostate cancer-associated CD44v6 using phage display selected peptides
There is a crucial need to identify new biomarkers associated with aggressive prostate cancer (PCa) including those associated with cancer stem cells (CSCs). CD44v6, generated by alternative splicing of CD44, has been proposed as a CSC biomarker due to its correlation with aggressive PCa disease. We...
Zapisane w:
| Wydane w: | Oncotarget |
|---|---|
| Główni autorzy: | , , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Impact Journals LLC
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5689723/ https://ncbi.nlm.nih.gov/pubmed/29156833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.21421 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|